Skip to main content
Article thumbnail
Location of Repository

The multidrug resistance 1 (MDR1) gene polymorphism G-rs3789243-A is not associated with disease susceptibility in Norwegian patients with colorectal adenoma and colorectal cancer; a case control study

By Vibeke Andersen, Lene Agerstjerne, Dorte Jensen, Mette Østergaard, Mona Sæbø, Julian Hamfjord, Elin Kure and Ulla Vogel
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2008). A haplotype of polymorphisms in ASE-1, RAI and ERCC1 and the effects of tobacco smoking and alcohol consumption on risk of colorectal cancer: a Danish prospective case-cohort study.
  2. (2007). A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women. Oncol Rep
  3. (2006). ABCB1/MDR1 gene determines susceptibility and phenotype in ulcerative colitis: discrimination of critical variants using a gene-wide haplotype tagging approach. Hum Mol Genet
  4. (2006). Alcohol and cancer. Lancet Oncol
  5. (2008). Alcohol consumption and risk of colorectal cancer: the Findrink study.
  6. (2001). An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev
  7. (2003). and colorectal cancer: a summary of the epidemiologic evidence. J Womens Health (Larchmt)
  8. (2006). Andriulli A: Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis. World J Gastroenterol
  9. (2008). Béziau S: Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study.
  10. (2009). Cyclooxygenase-2, multidrug resistance 1, and breast cancer resistance protein gene polymorphisms and inflammatory bowel disease in the Danish population.
  11. (2007). Dagiliene E, et al.: Mutations in CARD15 and smoking confer susceptibility to Crohn's disease in the Danish population.
  12. (2008). Detailed assessment of NOD2/CARD15 exonic variation in inflammatory bowel disease in Scotland: implications for disease pathogenesis. Genes Immun
  13. (2006). Drosophila melanogaster p-glycoprotein: a membrane detoxification system toward polycyclic aromatic hydrocarbon pollutants. Environ Toxicol Chem
  14. (2002). Effects of polymorphisms of MDR1, MRP1, and MRP2 genes on their mRNA expression levels in duodenal enterocytes of healthy Japanese subjects. Biol Pharm Bull
  15. (2007). et al.: Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers.
  16. (2006). et al.: Effects of genetic polymorphisms of MDR1, FMO3 and CYP1A2 on susceptibility to colorectal cancer in Koreans. Cancer Sci
  17. (2004). et al.: Haplotype-oriented genetic analysis and functional assessment of promoter variants in the MDR1 (ABCB1) gene. J Pharmacol Exp Ther
  18. (2005). et al.: Polymorphism in the P-glycoprotein drug transporter MDR1 gene in colon cancer patients.
  19. (2005). Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver. Biochem Pharmacol
  20. (2007). Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab Dispos
  21. (2000). Functional polymorphisms of the human multidrugresistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA
  22. (1988). HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res
  23. (2004). Hirschhorn JN: In genetic control of disease, does 'race' matter? Nat Genet
  24. (2007). Human intestinal P-glycoprotein activity estimated by the model substrate digoxin.
  25. (2003). Human MDR1 polymorphism: G2677T/A and C3435T have no effect on MDR1 transport activities. Biochem Pharmacol
  26. (2003). Immunohistochemical studies on the expression of P-glycoprotein and p53 in relation to histological differentiation and cell proliferation in hepatocellular carcinoma. Hepatol Res
  27. (2008). Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Carcinogenesis
  28. (2002). K: A comprehensive review of genetic association studies. Genet Med
  29. (2001). Koenig W: Effect of alcohol consumption on systemic markers of inflammation. Lancet
  30. (2005). Lifestyle-related risk factors and chemoprevention for colorectal neoplasia: experience from the large-scale NORCCAP screening trial.
  31. (2007). Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas.
  32. (2000). MJ: Multiple physiological functions for multidrug transporter P-glycoprotein? Trends Biochem Sci
  33. (2002). Modifiable risk factors for colon cancer. Gastroenterol Clin North Am
  34. (2005). Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics
  35. (2008). NORCCAP: Norwegian Colorectal Cancer Prevention Trial
  36. (2007). P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines. Cancer Res
  37. (2004). Paabo S: Evidence for gradients of human genetic diversity within and among continents. Genome Res
  38. (2006). Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study.
  39. Power/Sample Size Calculation for Logistic Regression with Binary Covariate(s)
  40. (2003). Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics
  41. (1997). The physiological function of drug-transporting P-glycoproteins. Semin Cancer Biol
  42. (2006). Tinetti ME: The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med
  43. (2006). Tobacco smoking: a factor of early onset of colorectal cancer. Dis Colon Rectum
  44. (2007). Turgut G: MDR1 C3435T polymorphism in patients with breast cancer. Arch Med Res
  45. (2006). Varadi A: Human multidrug resistance ABCB and ABCG transporters: participation in a chemoimmunity defense system. Physiol Rev

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.